2022 Q4 Form 10-K Financial Statement

#000106299322022865 Filed on November 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $159.9K $189.8K $538.8K
YoY Change 53.36% 27.69% -9.12%
% of Gross Profit
Research & Development $15.53K $297.9K $808.8K
YoY Change 26.64% 3384.21% 3855.01%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $178.4K $487.7K $1.566M
YoY Change 53.11% 210.27% 155.35%
Operating Profit -$178.4K -$1.566M
YoY Change 52.5% 154.76%
Interest Expense -$268.5K -$318.8K $6.251K
YoY Change -95982.14% -65163.27% -85.46%
% of Operating Profit
Other Income/Expense, Net $21.20K -$4.532M $57.33K
YoY Change -77.07%
Pretax Income -$446.8K -$806.5K $1.974M
YoY Change 284.47% 257.36% -607.08%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$446.8K -$806.5K $1.974M
YoY Change 284.47% 257.36% -607.08%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 -$5.197K $0.01
COMMON SHARES
Basic Shares Outstanding 155.1M shares 151.0M shares
Diluted Shares Outstanding 155.1M shares 152.0M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.625M $3.059M $3.059M
YoY Change 598.43% 728.36% 728.36%
Cash & Equivalents $448.7K $615.2K $615.2K
Short-Term Investments $2.176M $2.444M $2.444M
Other Short-Term Assets $111.7K $139.3K $139.3K
YoY Change 270.23% 237.64% 237.64%
Inventory
Prepaid Expenses $111.7K $139.3K
Receivables $7.039K $4.877K $4.880K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.744M $3.203M $3.203M
YoY Change 565.83% 671.66% 671.66%
LONG-TERM ASSETS
Property, Plant & Equipment $10.50K $10.50K $10.50K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.50K $10.50K $10.50K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.744M $3.203M $3.203M
Total Long-Term Assets $10.50K $10.50K $10.50K
Total Assets $2.754M $3.214M $3.214M
YoY Change 568.38% 674.19% 674.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $296.8K $293.4K $293.5K
YoY Change 2.68% -5.12% -5.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $345.4K $357.9K $357.9K
YoY Change -9.02% -14.98% -14.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $345.4K $357.9K $357.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $345.5K $357.9K $357.9K
YoY Change -9.02% -14.99% -14.99%
SHAREHOLDERS EQUITY
Retained Earnings -$13.14M -$12.69M
YoY Change -13.46%
Common Stock $155.1K $155.1K
YoY Change 11.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.409M $2.856M $2.856M
YoY Change
Total Liabilities & Shareholders Equity $2.754M $3.214M $3.214M
YoY Change 568.38% 674.19% 674.18%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$446.8K -$806.5K $1.974M
YoY Change 284.47% 257.36% -607.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$166.5K -$419.0K -$970.0K
YoY Change 32.93% 280.89% 137.64%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.50K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $1.110M
YoY Change 261.38%
Cash From Investing Activities $0.00 $0.00 $1.100M
YoY Change 257.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 $131.4K
YoY Change -100.0% -100.0% -67.94%
NET CHANGE
Cash From Operating Activities -$166.5K -419.0K -$970.0K
Cash From Investing Activities $0.00 0.000 $1.100M
Cash From Financing Activities $0.00 0.000 $131.4K
Net Change In Cash -$166.5K -419.0K $260.9K
YoY Change -2811.68% -1538.45% -15.49%
FREE CASH FLOW
Cash From Operating Activities -$166.5K -$419.0K -$970.0K
Capital Expenditures $0.00 -$10.50K
Free Cash Flow -$419.0K -$959.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3293224 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17705 usd
CY2022 enrt Percentage Of Land Rights Interest
PercentageOfLandRightsInterest
1 pure
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
95992 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1974407 usd
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-7641 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
53488 usd
CY2022 enrt Proceeds From Sale Of Mineral Property
ProceedsFromSaleOfMineralProperty
1100000 usd
CY2021 enrt Proceeds From Sale Of Mineral Property
ProceedsFromSaleOfMineralProperty
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95992 usd
CY2022 enrt Net Proceeds From Subscriptions Received
NetProceedsFromSubscriptionsReceived
0 usd
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.07
CY2022 enrt Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod
226776 shares
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2022 dei Auditor Name
AuditorName
DAVIDSON & COMPANY LLP
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
64409 usd
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
111659 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2855786 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5841 usd
CY2021 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
69000 usd
CY2021 enrt Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
180000 usd
CY2022 enrt Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
131390 usd
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
163130 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2855786 usd
CY2022 us-gaap Interest Expense
InterestExpense
6251 usd
CY2021 us-gaap Interest Expense
InterestExpense
1416 usd
CY2022 us-gaap Lease Cost
LeaseCost
10404 usd
CY2021 us-gaap Lease Cost
LeaseCost
7042 usd
CY2022 us-gaap Communication
Communication
19 usd
CY2021 us-gaap Communication
Communication
75 usd
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
26732 usd
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-7641 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
53488 usd
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
69000 usd
CY2022 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
0 usd
CY2021 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
250000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-389368 usd
CY2022 enrt Marketable Securities Unrealized Gain Loss Total
MarketableSecuritiesUnrealizedGainLossTotal
-985921 usd
CY2021 enrt Marketable Securities Unrealized Gain Loss Total
MarketableSecuritiesUnrealizedGainLossTotal
-5680 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
69000 usd
CY2022 enrt Income From Royalty Grant
IncomeFromRoyaltyGrant
0 usd
CY2021 enrt Income From Royalty Grant
IncomeFromRoyaltyGrant
250000 usd
CY2021 enrt Net Proceeds From Subscriptions Received
NetProceedsFromSubscriptionsReceived
180000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2000000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.06
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-08-18
CY2021Q1 enrt Number Of Units Issued In Final Tranche Of Private Placement
NumberOfUnitsIssuedInFinalTrancheOfPrivatePlacement
3000000 shares
CY2021Q1 enrt Units Issue Price
UnitsIssuePrice
0.06
CY2021Q1 enrt Gross Proceeds Of Units Issued In Final Tranche Of Private Placement
GrossProceedsOfUnitsIssuedInFinalTrancheOfPrivatePlacement
180000000 usd
CY2021Q1 enrt Description Of Units Issuance In Private Placement
DescriptionOfUnitsIssuanceInPrivatePlacement
Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance
CY2021Q1 enrt Purchase Price Per Share To Purchase One Additional Common Share
PurchasePricePerShareToPurchaseOneAdditionalCommonShare
0.09
CY2021 enrt Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
2720000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.02 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0226 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 enrt Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.05
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3500000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2022Q3 us-gaap Share Price
SharePrice
0.048
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.04
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4973369 shares
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2430960 usd
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2853193 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10259316 usd
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
10500000 usd

Files In Submission

Name View Source Status
0001062993-22-022865-index-headers.html Edgar Link pending
0001062993-22-022865-index.html Edgar Link pending
0001062993-22-022865.txt Edgar Link pending
0001062993-22-022865-xbrl.zip Edgar Link pending
enrt-20220831.xsd Edgar Link pending
exhibit10-2.htm Edgar Link pending
exhibit10-3.htm Edgar Link pending
exhibit10-4.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
enrt-20220831_pre.xml Edgar Link unprocessable
enrt-20220831_lab.xml Edgar Link unprocessable
enrt-20220831_cal.xml Edgar Link unprocessable
enrt-20220831_def.xml Edgar Link unprocessable
form10k_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending